Sort by
Refine Your Search
-
and will contribute to key modeling and simulation deliverables for drug candidates across early and late stages of clinical development, spanning multiple therapeutic modalities. The Fellows will
-
of clinical development, spanning multiple therapeutic modalities. The Fellows will support project leads at Moderna by evaluating and implementing model-informed drug development (MIDD) strategies, including
-
, including participant recruitment and data collection. Support data analysis (experience analyzing longitudinal data preferred) and co-author peer-reviewed manuscripts. Contribute to grant development and
-
opportunity to work closely with our innovative biopharmaceutical industry partners, while engaging with Northeastern University faculty in professional and career development, teaching, service, and scholarly
-
the opportunity to work closely with our innovative biopharmaceutical industry partners, while engaging with Northeastern University faculty in professional and career development, teaching, service
-
ion channel for the treatment of several diseases. Such a candidate will support the preclinical drug discovery and development for early-stage therapeutic treatment of neuropathic pain, glaucoma
-
the opportunity to work closely with our innovative biopharmaceutical industry partners, while engaging with Northeastern University faculty in professional and career development, teaching, service
-
modulators of the GPCR receptor as well as ligand-gated ion channel for the treatment of several diseases. Such a candidate will support the preclinical drug discovery and development for early-stage
-
the opportunity to work closely with our innovative biopharmaceutical industry partners, while engaging with Northeastern University faculty in professional and career development, teaching, service
-
funding and performance. This position will be based in the Social Development and Wellbeing Lab led by Dr. Alexandra Rodman. The Lab and offices are the heart of Boston, in the new, state-of-the-art ISEC